64 related articles for article (PubMed ID: 26967391)
1. Serum GRP78 as a Tumor Marker and Its Prognostic Significance in Non-Small Cell Lung Cancers: A Retrospective Study.
Ma X; Guo W; Yang S; Zhu X; Xiang J; Li H
Dis Markers; 2015; 2015():814670. PubMed ID: 26265795
[TBL] [Abstract][Full Text] [Related]
2. The serum tenascin C level is a marker of metabolic disorder-related inflammation affecting pancreatic cancer prognosis.
Sato K; Hikita H; Shigekawa M; Soma K; Yamauchi R; Sung J; Kato S; Sasaki Y; Kudo S; Fukumoto K; Shirai K; Murai K; Tahata Y; Yoshioka T; Nishio A; Saito Y; Kodama T; Sasaki Y; Tatsumi T; Takehara T
Sci Rep; 2024 May; 14(1):12028. PubMed ID: 38797735
[TBL] [Abstract][Full Text] [Related]
3. Advance in predictive and prognostic marker assessments in lung cancer.
Mino-Kenudson M
Transl Lung Cancer Res; 2017 Oct; 6(5):499-500. PubMed ID: 29114465
[No Abstract] [Full Text] [Related]
4. Extracellular Matrix and Dermal Fibroblast Function in the Healing Wound.
Tracy LE; Minasian RA; Caterson EJ
Adv Wound Care (New Rochelle); 2016 Mar; 5(3):119-136. PubMed ID: 26989578
[No Abstract] [Full Text] [Related]
5. Phosphatase of regenerating liver-3 inhibits invasiveness and proliferation in non-small cell lung cancer by regulating the epithelial-mesenchymal transition.
Lin SY; Lee YX; Yu SL; Chang GC; Chen JJ
Oncotarget; 2016 Apr; 7(16):21799-811. PubMed ID: 26967563
[TBL] [Abstract][Full Text] [Related]
6. Tenascin-C modulates alveolarization in bronchopulmonary dysplasia.
Liu W; Mao Y; Lv Q; Lu K; Yin C; Cheng R; Zhang M
Inflamm Regen; 2024 Mar; 44(1):16. PubMed ID: 38539268
[TBL] [Abstract][Full Text] [Related]
7. Tissue Rigidity Increased during Carcinogenesis of NTCU-Induced Lung Squamous Cell Carcinoma In Vivo.
Zakaria MA; Aziz J; Rajab NF; Chua EW; Masre SF
Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289644
[TBL] [Abstract][Full Text] [Related]
8. Revisiting the Tenascins: Exploitable as Cancer Targets?
Tucker RP; Degen M
Front Oncol; 2022; 12():908247. PubMed ID: 35785162
[TBL] [Abstract][Full Text] [Related]
9. Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer.
Kiebish MA; Cullen J; Mishra P; Ali A; Milliman E; Rodrigues LO; Chen EY; Tolstikov V; Zhang L; Panagopoulos K; Shah P; Chen Y; Petrovics G; Rosner IL; Sesterhenn IA; McLeod DG; Granger E; Sarangarajan R; Akmaev V; Srinivasan A; Srivastava S; Narain NR; Dobi A
J Transl Med; 2020 Jan; 18(1):10. PubMed ID: 31910880
[TBL] [Abstract][Full Text] [Related]
10. Genomic alterations of Tenascin C in highly aggressive prostate cancer: a meta-analysis.
Mishra P; Kiebish MA; Cullen J; Srinivasan A; Patterson A; Sarangarajan R; Narain NR; Dobi A
Genes Cancer; 2019; 10(5-6):150-159. PubMed ID: 31798767
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Role of Tenascin-C for Cancer Outcome: A Meta-Analysis.
Ming X; Qiu S; Liu X; Li S; Wang Y; Zhu M; Li N; Luo P; Liang C; Tu J
Technol Cancer Res Treat; 2019 Jan; 18():1533033818821106. PubMed ID: 30803361
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNAs RP5-821D11.7, APCDD1L-AS1 and RP11-277P12.9 were associated with the prognosis of lung squamous cell carcinoma.
Luo Y; Xuan Z; Zhu X; Zhan P; Wang Z
Mol Med Rep; 2018 May; 17(5):7238-7248. PubMed ID: 29568882
[TBL] [Abstract][Full Text] [Related]
13. High serum haptoglobin level is associated with tumor progression and predicts poor prognosis in non-small cell lung cancer.
Lu J; Wang Y; Yan M; Feng P; Yuan L; Cai Y; Xia X; Liu M; Luo J; Li L
Oncotarget; 2016 Jul; 7(27):41758-41766. PubMed ID: 27248178
[TBL] [Abstract][Full Text] [Related]
14. Tenascin-C serum levels and its prognostic power in non-small cell lung cancer.
Gebauer F; Gelis S; Zander H; Meyer KF; Wolters-Eisfeld G; Izbicki JR; Bockhorn M; Tachezy M
Oncotarget; 2016 Apr; 7(15):20945-52. PubMed ID: 26967391
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and Prognostic Value of Serum Angiopoietin-Like Protein 2 in Patients with Non-Small Cell Lung Cancer.
Chen Y; Jiang H; Zhu L; Wang P; Liu S; Xiao X; Yu H; Dong W
Clin Lab; 2017 Jan; 63(1):59-65. PubMed ID: 28164488
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic value of serum Cripto-1 in patients with non-small cell lung cancer.
Xu CH; Chi CZ; Zhang Q; Wang YC; Wang W; Yuan Q; Zhan P; Zhang XW; Lin Y
Clin Respir J; 2018 Oct; 12(10):2469-2474. PubMed ID: 29570945
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
Fan J; Yu H; Lv Y; Yin L
Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
[TBL] [Abstract][Full Text] [Related]
18. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
[TBL] [Abstract][Full Text] [Related]
19. Serum Human Epididymis Secretory Protein 4 (HE4) is a Potential Prognostic Biomarker in Non-Small Cell Lung Cancer.
Mo D; He F
Clin Lab; 2018 Sep; 64(9):1421-1428. PubMed ID: 30274019
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
